Dyslexia Treatment Market Growth Statistics, Regional Analysis, Top Players, Size, And Forecast To 2033

"The new report published by The Business Research Company, titled Dyslexia Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the dyslexia treatment market size has grown strongly in recent years. It will grow from $26.36 billion in 2023 to $28.14 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The dyslexia treatment market size is expected to see strong growth in the next few years. It will grow to $37.06 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16402&type=smp

Growing Prevalence Of Neurological Disorders Drives Dyslexia Treatment Market Expansion
An increase in the prevalence of neurological disorders is expected to propel the growth of the dyslexia treatment market going forward. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves. The prevalence of neurological disorders is increasing due to factors such as an aging population, lifestyle changes, environmental factors, and improved diagnostic techniques that lead to better detection and reporting of these conditions. Dyslexia treatments, such as multisensory learning and cognitive training, show the potential to improve neurological disorders by enhancing brain plasticity and cognitive functions. For instance, in March 2024, according to the according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 3 billion people globally were living with a neurological condition. Additionally, over 80% of deaths and health losses due to neurological conditions occur in low- and middle-income countries. Access to treatment varies significantly, with high-income countries having up to 70 times more neurological professionals per 100,000 people than low- and middle-income countries. Therefore, an increase in the prevalence of neurological disorders is driving the growth of the dyslexia treatment market.

Development Of Personalized Solutions In Dyslexia Treatment
Major companies operating in the dyslexia treatment market are focusing on developing advanced solutions, such as customized programs, to better serve customers. Customized programs refer to individualized educational plans and interventions tailored to meet the specific learning needs of students with dyslexia. For instance, in May 2021, Microsoft Corporation, a US-based technology company, partnered with Made by Dyslexia, a UK-based provider of philanthropic fundraising services, to launch a free online training program to assist teachers in identifying and supporting students with dyslexia. This initiative aims to equip educators with the knowledge to recognize both the strengths and challenges of dyslexic learners and to develop the skills needed to create inclusive classrooms. The training modules address various aspects of dyslexia awareness, effective teaching strategies, and technology tools designed to support dyslexic learners.

The dyslexia treatment market covered in this report is segmented -

1) By Type: Double Deficit Dyslexia, Visual Dyslexia, Phonological Dyslexia, Other Types
2) By Therapy: Occupational Therapy, Speech Therapy, Cognitive Behavioural Therapy
3) By Drugs: Cyclizine, Meclizine, Dimenhydrinate, Methylphenidate, Other Drugs
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End Users: Psychiatric Institutions, Rehabilitation Centres, Home Care, Other End-users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16402&type=discount

Major companies operating in the dyslexia treatment market are Pfizer Inc., Astrazeneca Plc, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma, Apotex Corporation, Endo International Plc, Amneal Pharmaceuticals LLC, Unither Pharmaceuticals LLC, RPG Life Sciences Ltd., Jubilant Pharma Limited, Breckenridge Pharmaceutical Inc., Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd, Lexia Learning Systems LLC, Wallace Pharmaceuticals Ltd., Ironshore Pharmaceuticals Inc., DK Pharmachem Pvt Ltd., Speechify Inc., Lingit AS, Lyfta, Nessy Learning Ltd.

Contents of the report:
1. Executive Summary
2. Dyslexia Treatment Market Report Structure
3. Dyslexia Treatment Market Trends And Strategies
4. Dyslexia Treatment Market - Macro Economic Scenario
5. Dyslexia Treatment Market Size And Growth
…..
27. Dyslexia Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/dyslexia-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.